Search results
Results from the WOW.Com Content Network
%PDF-1.6 %âãÏÓ 1327 0 obj > endobj 1344 0 obj >/Filter/FlateDecode/ID[8A464830F3F447577F700997159A8D8A>7386F6352A78EA45874F195DAE6058FE>]/Index[1327 30]/Info 1326 ...
We conduct clinical and translational research that positively impacts patients through the prevention and treatment of gynecologic malignancies, including cancers that arise from the ovaries, uterus, cervix, vagina, and vulva.
The Gynecologic Oncology Group (GOG) is founded and housed within the American College of Obstetricians and Gynecologists. For a more comprehensive review of GOG's history and research, download our book.
We conduct clinical trials specific to the treatment of gynecologic cancers, and our patients are screened by independent medical institutions. As such, we do not have medical personnel on our staff and cannot provide medical advice.
Endometrial Cancer: Highlight Reel. Brian M. Slomovitz, MD, MS, FACOG Professor, Florida International University Director, Gynecologic Oncology, Mount Sinai Medical Center Member, Board of Directors, GOG Foundation Uterine Cancer Lead, GOG Partners. November 19, 2021.
The GOG Foundation’s Education and Mentoring Committee develops the next generation of leaders in gynecologic oncology. Elise C. Kohn, MD – Head, NCI DCTD, Gynecologic Cancer Therapeutics. Michelle Small – GOG Foundation Administrative Support.
Selecting therapies and treatments for women with cervical, endometrial, and ovarian cancers. The GOG Highlight Reel Educational Series – Fall 2023. Presented on Thursday, November 30, 2023, 6:30 pm – 9:00 pm ET.
Leveraging our global content experts in all gynecologic oncology domains, the GOG Foundation developed Advisory Boards as a learning tool for Preferred Industry Collaboration Team Members. As clinicians and researchers, we are always seeking the next breakthrough in treatment for our patients.
NRG was formed from the amalgamation of three legacy cooperative groups, the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy On-cology Group (RTOG), and the Gynecologic Oncology Group (GOG).
Following his discovery of fetal warfarin syndrome as a resident, DiSaia would serve in the U.S. Navy and successfully compete for an American Cancer Society Grant that would fund his Fellowship in Gynecologic Oncology under the instruction of Dr Felix N. Rutledge at the MD Anderson Hospital and Tumor Institute in Houston, Texas.